Roivant Sciences

Forecast & Rating12 analysts currently cover Roivant Sciences, with about 91.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $41.82, about 15.2% upside from the current price of $36.31. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 51.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Roivant Sciences closely still see room for the stock to rise. Data as of Aug 20, 2026; for reference only and not investment advice.